DETQ is a selective, allosteric and orally active dopamine D1 receptor ( Dopamine Receptor ) potentiator. In HEK293 cells expressing the human D1 receptor, DETQ increases cAMP with an EC 50 of 5.8 nM and a K b of 26 nM. DETQ shows ~30-fold less potent at rat and mouse D1 receptors and is inactive at the human D5 receptor.
Products | Products > Disease Areas > Neurological, Eye or Ear Disease | Products > Signaling Pathways > GPCR/G Protein | Products > Signaling Pathways > Neuronal Signaling | Products > Research Areas > Neurological Disease | Products > Signaling Pathways > Dopamine Receptor
Please leave a message for us or use the following ways to contact us, we will reply to you as soon as possible, and provide you with the most sincere service, thank you.